Breaking News Instant updates and real-time market news.

RYI

Ryerson

$9.30

0.35 (3.91%)

17:22
05/19/17
05/19
17:22
05/19/17
17:22

Ryerson exec acquires 2,200 common shares

In a regulatory filing, Ryerson Holding North West Region president Michael Burbach disclosed the purchase of 2,200 common shares at a price of $9.05 per share. The transaction brings Burbach's total direct common stock ownership to 50,000 shares.

RYI Ryerson
$9.30

0.35 (3.91%)

11/09/16
DBAB
11/09/16
UPGRADE
DBAB
Buy
Deutsche upgrades four Metals & Mining names after Trump win
Deutsche Bank analyst Jorge Beristain believes Metals & Mining companies with exposure to precious metals and steel and aluminum will benefit from trade protectionism under President-elect Donald Trump. The analyst upgraded to Buy from Hold Franco-Nevada (FNV), Reliance Steel (RS), Ryerson (RYI) and U.S. Steel (X). Higher import duties and/or regulations for aluminum and steel products are likely, which should "provide a tailwind" for domestic steel and aluminum prices, Beristain tells investors in a research note. The analyst has a $74 price target for Franco-Nevada, a $78 target for Reliance, a $14 target for Ryerson and a $24 target for U.S. Steel.
01/09/17
KEYB
01/09/17
UPGRADE
KEYB
Overweight
Ryerson upgraded to Overweight from Sector Weight at KeyBanc
01/09/17
KEYB
01/09/17
NO CHANGE
KEYB
Steel stocks upgraded at KeyBanc
As noted earlier, KeyBanc upgraded Nucor (NUE), Reliance Steel (RS), Ryerson (RYI), and Olympic Steel (ZEUS) to Overweight from Sector Weight. The firm expects the supply/demand dynamics of the U.S. steel sector to become "more balanced," "driven by improving demand expectations." The firm raised its 2017 carbon steel demand growth forecast to 2.1% from 1.5%, citing higher demand from the energy sector and stronger "industrial momentum." It placed a $70 price target on Nucor, a $92 price target on Reliance Steel, an $18 price target on Ryerson, and a $28 price target on Zeus.
01/13/17
KEYB
01/13/17
NO CHANGE
KEYB
Ryerson should be bought on any weakness, says KeyBanc
After Ryerson preannounced lower than expected Q4 LIFO EBITDA, KeyBanc says its upbeat 2017 and 2018 guidance outlook for the company "remains intact." The firm says that the company is well-positioned to benefit from a recovery in the industrial sector and is poised to reduce its debt. The firm keeps an $18 price target and an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

10:17
12/14/17
12/14
10:17
12/14/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
12/14/17
12/14
10:16
12/14/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/14/17
12/14
10:15
12/14/17
10:15
General news
U.S. business inventories dipped 0.1% in October with sales up 0.6% »

U.S. business inventories…

10:15
12/14/17
12/14
10:15
12/14/17
10:15
General news
Breaking General news story  »

Week of 12/8 EIA Natural…

LUXTY

Luxottica

$59.55

0.05 (0.08%)

, LUX

Symbol now LUXTY

10:12
12/14/17
12/14
10:12
12/14/17
10:12
Periodicals
Luxottica, Essilor deal expected to win unconditional EU approval, Reuters says »

The proposed $56.8B…

LUXTY

Luxottica

$59.55

0.05 (0.08%)

LUX

Symbol now LUXTY

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.12

-0.0046 (-3.60%)

10:10
12/14/17
12/14
10:10
12/14/17
10:10
Hot Stocks
Jaguar Health, Seed Mena enter collaboration agreement with Equilevia »

Jaguar Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

SLV

iShares Silver Trust

$14.96

-0.19 (-1.25%)

10:10
12/14/17
12/14
10:10
12/14/17
10:10
Options
Second day of interest in iShares Silver call options »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$5.03

0.02 (0.40%)

10:04
12/14/17
12/14
10:04
12/14/17
10:04
Hot Stocks
Pandora to offer ad-supported listeners access to on-demand listening »

Pandora announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHDX

Genomic Health

$28.00

-2.05 (-6.82%)

10:02
12/14/17
12/14
10:02
12/14/17
10:02
Hot Stocks
Genomic Health heads higher after Bloomberg report on sale exploration »

Shares of Genomic Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:01
12/14/17
12/14
10:01
12/14/17
10:01
General news
Business Inventories data reported »

October Business…

GOGO

Gogo

$10.39

-0.22 (-2.07%)

, DAL

Delta Air Lines

$54.30

0.67 (1.25%)

10:01
12/14/17
12/14
10:01
12/14/17
10:01
Hot Stocks
Gogo higher after Delta buys 100 planes with 2Ku Wi-Fi »

Shares of Gogo (GOGO) are…

GOGO

Gogo

$10.39

-0.22 (-2.07%)

DAL

Delta Air Lines

$54.30

0.67 (1.25%)

EADSY

Airbus

$26.16

0.62 (2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AGN

Allergan

$169.34

0.1 (0.06%)

10:01
12/14/17
12/14
10:01
12/14/17
10:01
Rumors
Rumor moving shares of Allergan »

Rumor: Allergan moves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

TEVA

Teva

$18.00

2.2982 (14.64%)

10:00
12/14/17
12/14
10:00
12/14/17
10:00
Options
Teva in-the-money calls active as shares spike »

Teva in-the-money calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

10:00
12/14/17
12/14
10:00
12/14/17
10:00
General news
U.S. December Markit manufacturing PMI jumped 1.1 points to 55.0 »

U.S. December Markit…

GBTC

Bitcoin Investment Trust

$2,335.00

62 (2.73%)

09:59
12/14/17
12/14
09:59
12/14/17
09:59
Periodicals
Citron puts fair value of Bitcoin Investment Trust at $1,600 »

Citron Research just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAN

Banco Santander

$6.67

0.0832 (1.26%)

09:58
12/14/17
12/14
09:58
12/14/17
09:58
Hot Stocks
Breaking Hot Stocks news story on Banco Santander »

Banco Santander raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$108.26

0.65 (0.60%)

, FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

09:57
12/14/17
12/14
09:57
12/14/17
09:57
Recommendations
Disney, 21st Century Fox analyst commentary  »

Fox deal brings…

DIS

Disney

$108.26

0.65 (0.60%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

TIF

Tiffany

$100.49

4.39 (4.57%)

, MYL

Mylan

$39.53

0.24 (0.61%)

09:55
12/14/17
12/14
09:55
12/14/17
09:55
Options
Early notable gainers among liquid option names on December 14th »

Notable gainers among…

TIF

Tiffany

$100.49

4.39 (4.57%)

MYL

Mylan

$39.53

0.24 (0.61%)

MAT

Mattel

$15.59

0.97 (6.63%)

ESRX

Express Scripts

$68.57

0.01 (0.01%)

MCK

McKesson

$158.35

3.14 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EACQ

Easterly Acquisition Corp

09:55
12/14/17
12/14
09:55
12/14/17
09:55
Conference/Events
Easterly Acquisition Corp to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VTGN

VistaGen Therapeutics

$1.17

-0.01 (-0.85%)

09:53
12/14/17
12/14
09:53
12/14/17
09:53
Hot Stocks
Breaking Hot Stocks news story on VistaGen Therapeutics »

Sabby reports 9.15%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHDX

Genomic Health

$28.00

-2.05 (-6.82%)

09:52
12/14/17
12/14
09:52
12/14/17
09:52
Hot Stocks
Breaking Hot Stocks news story on Genomic Health »

Genomic Health jumps 12%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHDX

Genomic Health

$28.00

-2.05 (-6.82%)

09:51
12/14/17
12/14
09:51
12/14/17
09:51
Periodicals
Breaking Periodicals news story on Genomic Health »

Genomic Health exploring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$267.20

0.45 (0.17%)

09:50
12/14/17
12/14
09:50
12/14/17
09:50
Options
Partial unwind in SPY vertical call spread locks in 370% winner »

Partial unwind in SPY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:50
12/14/17
12/14
09:50
12/14/17
09:50
General news
U.S. business inventories preview: »

U.S. business inventories…

09:46
12/14/17
12/14
09:46
12/14/17
09:46
General news
PMI Composite Flash Manufacturing â€' Level data reported »

December PMI Composite…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.